ArticleBrain & spine2026
Favourable outcome in a subset of ultra-severe traumatic brain injury patients - a single-centre retrospective study.
Article in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ultra-severe traumatic brain injury (us-TBI), defined as Glasgow Coma Scale score (GCS) of five-three, is associated with high mortality and severe morbidity amongst survivors. However, in selected patients a favourable recovery may still be achieved. Research question: We aimed to characterise what clinical parameters can be used as prognosticators in us-TBI patients. Material and method: A retrospective, single-centre study of 70 us-TBI patients admitted between the years of 2014-2024. Early clinical, and radiological factors were assessed, and patient outcome (Glasgow outcome scale extended- GOSE) was obtained at 3-12 months. Results: The median age was 52.5 years, 21 had GCS five on admission, 23 GCS four and 26 had GCS three. Four patients had on admission bilaterally dilated pupils, 35 patients had unilateral mydriasis, 11 had miotic pupils and 20 had normal pupils. Thirty-one patients (44%) succumbed to their injuries. Median GOSE was three, and nine patients (13%) achieved an excellent outcome (GOSE 7-8) - these patients were younger (median age 26 years) and showed normalised pupil reactivity post-operatively. A favourable outcome (GOSE≥5) was achieved in 19 patients (28%). A combination of GCS 3 and bilaterally dilated pupils was uniformly fatal. Discussion and conclusion: Despite presenting with a low level of consciousness (GCS 3-5) and pupillary abnormalities in 71%, survival was observed in 56% of us-TBI patients, and nine (13%) made an excellent recovery (GOSE 7-8). Improved pupillary reactivity post-intervention may be a positive prognosticator. Our data argue against therapeutic nihilism in us-TBI patient presenting with GCS scores of 5-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.